Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
TCL1A
REST API REST API
Homo sapiens
TCL1A is differentially expressed in 222 experiments: 62 organism parts: tonsil, bone marrow, ... (60 more);, 130 disease states: normal, Burkitt's lymphoma, ... (128 more);, 92 cell types 300 cell lines 23 compound treatments and 68 other conditions.
Synonyms TCL1
Orthologs ENSGALG00000023937 (Gallus gallus)   Tcl1 (Mus musculus)   TCL1A (Bos taurus)   Tcl1a (Rattus norvegicus)   TCL1A (Canis familiaris)   (Compare orthologs)
Gene Ontology Term endoplasmic reticulum, protein binding, stem cell maintenance, cytoplasm, cell cortex, microsome, multicellular organismal development, nucleus, pronucleus
InterPro Term TCL1_MTCP1
UniProt Accession P56279
Search EB-eye ENSG00000100721
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-GEOD-22541, E-GEOD-7224, ... (22 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-5258, E-GEOD-4525, E-GEOD-1880, E-GEOD-22639, ... (20 experiments)

Factor Value U/D Experiments
MOLT4
2
E-MTAB-62, E-MTAB-37
Hmec-1, TNF-stimulated
1
E-MTAB-62
NA18523
1
E-GEOD-19480
MRC5
1
E-MTAB-62
NCIH2195
1
E-MTAB-37
LS1034
1
E-MTAB-37
294 more value(s).


Cell type

studied in E-GEOD-3920, E-MEXP-120, E-GEOD-20677, E-GEOD-13909, E-GEOD-4219, ... (38 experiments)

Factor Value U/D Experiments
CD19+ B cells (neg. sel.)
2
E-AFMX-5, E-TABM-145
endothelial cell
1
2
E-GEOD-19240, E-GEOD-3920, E-GEOD-3998
M1 macrophage
1
E-GEOD-5099
embryonic stem cell
1
E-MEXP-930
iPS cells from episomal vectors (Defined Factor)
1
E-GEOD-20033
BDCA1+ dendritic cell
1
E-TABM-34
86 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-GEOD-1577, E-GEOD-2549, ... (42 experiments)

Factor Value U/D Experiments
chronic lymphocytic leukemia
3
E-GEOD-6691, E-GEOD-2466, E-MTAB-37
lung adenocarcinoma
3
E-MTAB-37, E-MTAB-62, E-MEXP-231
cervical carcinoma
2
E-GEOD-5823, E-MTAB-62
acute promyelocytic leukemia
2
E-MTAB-62, E-GEOD-995
Daudi Burkitt's lymphoma
2
E-AFMX-5, E-TABM-145
lung cancer, cytotoxicity
1
E-MTAB-62
124 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-5824, E-GEOD-3720, E-MEXP-1958, E-MEXP-941, ... (13 experiments)

Factor Value U/D Experiments
nocodazole
1
E-GEOD-5258
1,2,4-benzenetriol
1
E-GEOD-7664
control
30
1
E-GEOD-7664
docosahexaenoic acid
1
E-MEXP-1014
unknown
1
E-GEOD-7307
5-aza-2'-deoxycytidine + trichostatin A
2
1
E-MEXP-1269
17 more value(s).


Age at diagnosis

studied in E-GEOD-3494, E-GEOD-21653

Factor Value U/D Experiments
70
2
1
E-GEOD-21653
39
1
1
E-GEOD-3494


Age at onset
studied in E-GEOD-21521

Agent
studied in E-GEOD-19519

Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21374, ... (9 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-1140, E-GEOD-22513, ... (10 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-3140, E-MEXP-2359, E-GEOD-6236, E-GEOD-4667, ... (6 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-GEOD-21138, E-GEOD-19665

Environmental stress
studied in E-GEOD-1643, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-GEOD-7578, E-MEXP-563

Genotype
studied in E-TABM-1029, E-GEOD-2466, E-TABM-321, E-TABM-868, E-GEOD-21243, ... (6 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-GEOD-22278, E-GEOD-9764, E-MEXP-1103, ... (7 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-5764, E-TABM-740, E-GEOD-2466, ... (35 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12108, E-MEXP-561, E-GEOD-980

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-12662

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Material type
studied in E-MEXP-455, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Organism
studied in E-AFMX-1, E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-22229, E-GEOD-19703, E-GEOD-1309, E-GEOD-1493, E-MEXP-1403 ... (5 experiments)

Population
studied in E-MTAB-197, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246 ... (5 experiments)

Replicate
studied in E-GEOD-18791

RNAi
studied in E-MEXP-101, E-GEOD-3697

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-2466, E-GEOD-7307, E-TABM-147

Stimulation
studied in E-GEOD-20114, E-GEOD-11886

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276, E-GEOD-2748

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-GEOD-21909, E-GEOD-19246, E-GEOD-19815, ... (7 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Vehicle
studied in E-GEOD-5258

Processing time: 0.403 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM